Received: from DU7P191CA0016.EURP191.PROD.OUTLOOK.COM (2603:10a6:10:54e::26) by DU0PR02MB9848.eurprd02.prod.outlook.com (2603:10a6:10:448::8) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.181.8; Wed, 1 Jul 2026 13:49:10 +0000 Received: from DU0PR02MB9848.eurprd02.prod.outlook.com (2603:10a6:10:448::8) by DB9PR02MB7817.eurprd02.prod.outlook.com with HTTPS; Wed, 1 Jul 2026 13:49:44 +0000 Received: from mail1.rit.ee (213.184.53.4) by DB1PEPF00039230.mail.protection.outlook.com (10.167.8.103) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.21.181.6 via Frontend Transport; Wed, 1 Jul 2026 13:49:10 +0000 Received: from DB1PEPF00039230.eurprd03.prod.outlook.com (2603:10a6:10:54e:cafe::92) by DU7P191CA0016.outlook.office365.com (2603:10a6:10:54e::26) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.21.181.8 via Frontend Transport; Wed, 1 Jul 2026 13:49:10 +0000 Reply-To: From: =?utf-8?Q?EDQM=2C_Council_of_Europe_/_Consei?= =?utf-8?Q?l_de_l=E2=80=99Europe?= To: "Info - SOM" Subject: =?utf-8?Q?Help_shape_the_EDQM_Mid-Term_Str?= =?utf-8?Q?ategy_2028-2031_/_Contribuez_=C3=A0_b?= =?utf-8?Q?=C3=A2tir_la_strat=C3=A9gie_=C3=A0_moyen_terme_?= =?utf-8?Q?de_l=E2=80=99EDQM_=282028-2031=29=E2=80=8B?= Date: Wed, 1 Jul 2026 15:00:01 +0300 Keywords: Mall Message-ID: <54654.3032.289089.20260701120001.639185040019326321@info.edqm-info.eu> MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="----=_NextPart_000_0018_01DD09FC.15B2A260" X-Mailer: Microsoft Outlook 16.0 Thread-Index: AQGwz0vCrR2KkZXbZPegiyZetp+TQA== Authentication-Results: spf=softfail (sender IP is 213.184.53.4) smtp.mailfrom=info.edqm-info.eu; dkim=pass (signature was verified) header.d=edqm-info.eu;dmarc=pass action=none header.from=edqm-info.eu;compauth=pass reason=100 X-CSE-ConnectionGUID: UdqHv1WHTf+iJZT/SBlkuQ== X-CSE-MsgGUID: jzL6GJ1ZRfaMxut+oUladg== X-ThreatScanner-Verdict: Negative X-IPAS-Result: =?us-ascii?q?A0EmAAB6GUVqb47VrtlQChkBAQEBAQESAQEBAQEBAQEBA?= =?us-ascii?q?QEBAQEBAQEBAQEBAQEBgXwEAQEBAQELAQGBO1spGwECbIESBB42A4QZPINPi?= =?us-ascii?q?TmEbIEWFpxyFIErFhIQAQMSAQEBAQEBOgEFHQQBAQMBA4Q5Z40tIAcBNAkOA?= =?us-ascii?q?QIBAgEDAgMBAQEBAQEBAQEBAQsBAQEEAQEBAgEBAgQDAQEBAQIQATMLBUmGT?= =?us-ascii?q?w1JAQEBAQEBAQEFBIFbCAIGUXFjCDoBAQEBAQEBAQEBAQEBAQEBAQEBAQEBA?= =?us-ascii?q?RMCHxEQKykJDAsKEwEBBAgbARAGCAUFOgECBwICAy0bIAQBBA8JBIJigiICT?= =?us-ascii?q?xQGnX2bBj0BeoEyH2JYgTQBAQYEAwICfUYBBQJDONoigSUJFAyBFRgBgjCCL?= =?us-ascii?q?GiDFgEqgTUBAoQEEIQBe0IwEIEMQXUFGzIDgXcCRQeBdBKBJyMBAgEEFIEMD?= =?us-ascii?q?YQIGYI3Gi+BXhlSKBIqPAUGLgJAAQEcEDkcbwUSAQEBBYETgW2CQhOBWoYTB?= =?us-ascii?q?wdhVUszLAFVExcLBwU+gSgDgQZuMh03bD4XCCxYGwcFOmOBDF+BAz2CGm6BN?= =?us-ascii?q?SMfAzl/gTB1WGYVMDWBAwERHgqBRwuBDAMLbT0WIQgMG0lCHRKMKUoZFw+BQ?= =?us-ascii?q?QSBDhQDRyUhEzcGIW5XAUCOGYRqKnaIXqc5ggAKKIFmgQSBCwWMHIJZknsEL?= =?us-ascii?q?4QEpmiGI5Jljgqbbi9gI4IOAQdzEoFfK4EYCUcDGQ+OLQsLHHgBA4JIgQHNO?= = ?us-ascii?q?XkCAQEBAQoCJwMBAQEHAgcBCwEBAwkBAYFTARRQiASBAF0MhXYCgUoBAQ?= X-Talos-CUID: 9a23:9qNhuGArEZNLhtr6ExRr7W4KQ/8FTnOezVXiHwiDI2JqVYTAHA== X-Talos-MUID: 9a23:MPJD9gahjPsD5+BTtS3I2h5AbfVS7a2LGF0R0pI7v8CIOnkl X-IronPort-Anti-Spam-Filtered: true X-IronPort-AV: E=Sophos;i="6.25,141,1779138000"; d="scan'208,217";a="74236380" X-Amp-Result: SKIPPED(no attachment in message) X-Amp-File-Uploaded: False X-MS-Exchange-Organization-ExpirationStartTime: 01 Jul 2026 13:49:10.3201 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-MS-Exchange-Organization-Network-Message-Id: 006ac795-5cf4-4b09-2862-08ded777873d X-EOPAttributedMessage: 0 X-EOPTenantAttributedMessage: 8fe098d2-428d-4bd4-9803-7195fe96f0e2:0 X-MS-Exchange-Organization-MessageDirectionality: Incoming X-MS-PublicTrafficType: Email X-MS-TrafficTypeDiagnostic: DB1PEPF00039230:EE_|DU0PR02MB9848:EE_|DB9PR02MB7817:EE_ X-MS-Exchange-Organization-AuthSource: DB1PEPF00039230.eurprd03.prod.outlook.com X-MS-Exchange-Organization-AuthAs: Anonymous X-MS-Office365-Filtering-Correlation-Id: 006ac795-5cf4-4b09-2862-08ded777873d X-MS-Exchange-AtpMessageProperties: SA|SL X-DisclaimerOO: 1 X-MS-Exchange-Organization-SCL: -1 X-Microsoft-Antispam: BCL:0;ARA:13230040|704161711799003|2092899012|5063199012|1032899013|12012899012|4022899009|4123199012|31052699007|39142699007|82310400026|69100299015|7049299003|3109299003|11063799006|16102099003|3113699003|4113699003|19002099009|5063699009|56012099006|55112099003|5023799004|18002099003|8096899003|21082099003|2066899003|13003099007; X-Forefront-Antispam-Report: CIP:213.184.53.4;CTRY:EE;LANG:fr;SCL:-1;SRV:;IPV:CAL;SFV:NSPM;H:mail1.rit.ee;PTR:mail1.rit.ee;CAT:NONE;SFS:(13230040)(704161711799003)(2092899012)(5063199012)(1032899013)(12012899012)(4022899009)(4123199012)(31052699007)(39142699007)(82310400026)(69100299015)(7049299003)(3109299003)(11063799006)(16102099003)(3113699003)(4113699003)(19002099009)(5063699009)(56012099006)(55112099003)(5023799004)(18002099003)(8096899003)(21082099003)(2066899003)(13003099007);DIR:INB; X-MS-Exchange-CrossTenant-OriginalArrivalTime: 01 Jul 2026 13:49:10.1121 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: 006ac795-5cf4-4b09-2862-08ded777873d X-MS-Exchange-CrossTenant-Id: 8fe098d2-428d-4bd4-9803-7195fe96f0e2 X-MS-Exchange-CrossTenant-AuthSource: DB1PEPF00039230.eurprd03.prod.outlook.com X-MS-Exchange-CrossTenant-AuthAs: Anonymous X-MS-Exchange-CrossTenant-FromEntityHeader: Internet X-MS-Exchange-Transport-CrossTenantHeadersStamped: DU0PR02MB9848 X-MS-Exchange-Transport-EndToEndLatency: 00:00:34.4115441 X-MS-Exchange-Processed-By-BccFoldering: 15.21.0181.008 X-MS-Exchange-ExternalInOutlookResult: NotEnabled X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(4710137)(4717077)(920097)(930201)(20251009189)(140003); X-Microsoft-Antispam-Message-Info: =?us-ascii?Q?9F+Zfo+UynCqcgAXHZ0Kh8SM2dP4l0WLaW7dy7qGwZorODTrT2uyahmnB9+k?= =?us-ascii?Q?zeAHwPBK08lI8T5ik4qPzVBLvwHynKYmEWWJfrh7xqk2VsDvxtQH9D3Xsten?= =?us-ascii?Q?H2BrdFgYaJOwxPEiQ4Wy26AbsYnd9BoDbglzvSV0Rc2qoicWqP2aKz0hzswX?= =?us-ascii?Q?fQ+zhSkp5AlMZGVXFSdi7ReQd9gmFpYgIhgxLwFU+xfqfKmZptUaGD2f/2cO?= =?us-ascii?Q?GXN88szGBtLS4SMCWIv8TWeL+P5Vf0NLjE2L5qkd/tv4E7ohhY7Q/UNn/htl?= =?us-ascii?Q?xs1vMhtWnahSyaNanK+JcfmO7612LsmktbVZ/jXA/8/AyvexYoF75Pq5JJhT?= =?us-ascii?Q?nIkDH6qRoUh8+D2nC9SHwlahB+zTFk1p/D1wPnxNvwpCFBWBF29jtqfnqmJl?= =?us-ascii?Q?LfwCDaHzm598zTYbKWEs95OUlsh3Pel40t+2BCioSItlFezdtMH6nvh/Hj34?= =?us-ascii?Q?TOyfLLZ9fxm0eDqeHrb2fmlFqMA098rvZ4kHN+1eF3In/dbS5MLg5NscQLeA?= =?us-ascii?Q?P71Pp0x8kVrWw+R9g+5WM/x4/ntGFZTfRiY3E7oRfZ1G/LcCBKq+P/Ljfu6x?= =?us-ascii?Q?AkUS2pSNI2r7oP38qF5fHxI5uTjUHSTgwPO+I2xY7E8l3xM6Ib0RBuqopMaB?= =?us-ascii?Q?MGoYQ61YVkYF7AofK+UuloJ5en9gvDR3gt2q/br6Ma+MGI83hCYDH8AQq2zj?= =?us-ascii?Q?0gBpQhr9tjX9qfBCmM2k4z7toP00qlf5ayXyQXSvbZbi8qAOqel QKGcRXzms?= =?us-ascii?Q?OMhY6lheNCx/mp1AZRCuRRIHR2ZJE10jFs7dyuY4v3AOYARSmZiDZyrYQ3ev?= =?us-ascii?Q?6IdFELyWC6ynK/X1W4K04HQy+CEENRyLmQlozm+/SlstZEfE7UmYtJKZAVwl?= =?us-ascii?Q?G1wza8FARKfzSYlP7sFA5RBK95w50WRTyhiJeDIgDMKibOYxfi3WhuAFs+25?= =?us-ascii?Q?S8GmC0oi3HzZ8oDtr8j7IlxFd+K5gN1oz1q9HumkGwB98rS7WUOi4FWNyfwL?= =?us-ascii?Q?IY9SeijcKfJcpn5wk9vS9+hLtU+UrWusUnaIUqAvHiMUGn5+WsN8LkpcPuNm?= =?us-ascii?Q?EWgE/QWlDaSeXR7X17Ed3cylwkIL0INEL1uqG/x5xhLndAYBb4jiFL2+JjJd?= =?us-ascii?Q?9g/wSZOcyWQgnAtkoQg0ppxhjdth4PEpRQDBsOu5n/7JUZio06AXiIb0p5LS?= =?us-ascii?Q?JE+SPZ6ms1xsDmCWJLJd3iJENQ9smrUmWMN0x1bNJIJhbCuCf4QHsdtWFHx+?= =?us-ascii?Q?TiSeYYoly6Sc5sWncGiXPZDaZPRNfyGGTrUW5+L+liPv0Fa2tJBXEFq7wsFe?= =?us-ascii?Q?VJM2xTZmtqkVJ02JHCeym6Q7FRpz3TXe28+sy23Vmyc5pQppVRKYwz899hR+?= =?us-ascii?Q?+z3PXNzDbs+O58BcpD2SUcDWoNoYojsI1m6qEK03iHtItSmzuupLdB8GChln?= =?us-ascii?Q?S37FndtJXU6ubE0jyV52bR/rt+PLD6nHk5yfYqRodL+azOURKG2Q7+K7nFU0?= =?us-ascii?Q?9wYtMgb6T3MCPCuZ1Qcql8YshN6awdF29Nmoq 5LQ/sdFbhu792KC5y/EvDgf?= =?us-ascii?Q?iQXx8pPvy8RCxTtvf4x3LtOqFS2M2V954laKP4EgGo7z7oJiueDVy/JTRx/8?= =?us-ascii?Q?bQfqyR5vwOx0r6hxrc/rQHD0LhvpvqPtLL1M+rTkULWRB+kvPV8n21TX9R+n?= =?us-ascii?Q?2U6CQjmG350WcZKVMqIBymgEfUxkAzruMibFDtLv+f8VrjeMtpVH1EsYi/9N?= =?us-ascii?Q?Ta8U2+D1RMgrIecArmfH6j3pKhBfx0QtcimLFoSRYRvbrK19h2qID+DFn8FH?= =?us-ascii?Q?oo5u6jVF09f2DLEN5gDYTPTzssNulxqoTaU8aOxF8HFXLopT2iXoJRHHa45W?= =?us-ascii?Q?2PS8As29wnvd841FRm6Rh9lG6FlNF8LSrqB8m9dQewVRt0nxSmTe5sf8jvxJ?= =?us-ascii?Q?uxwLyMLStVkSuEQlJ7LHxMsZRkqbl26pTURxVVagBS62b0dhpyyV+cW5tOsS?= =?us-ascii?Q?Hd8MF9Xr8L8MCXHUUPp5rSThi9fISxkLjqG99e5D7XE/h6hUazi/tjQDCHhw?= =?us-ascii?Q?Xj7cCGsQVbE3AU9y1mmC7mxLQd1aup/AiestgzDKx/ZPV013qS4yvmpSQa0e?= =?us-ascii?Q?PyeBiPbgoXEu//L6YC/tYeE0yu7Fi7feLwYjTnBmu1PhzjDvF4a2IB4+1g6g?= =?us-ascii?Q?Gm0QiVw+ZCrt52n2K0PbXo2PQNGMmY8onxGupzThVlXLm13hICoUKddiEhbz?= =?us-ascii?Q?ryAv/IdDp+CdA+ch46SFGFOADjWx2hhyB9GVFl8PKjgcZC1lf1xea6loG4MA?= =?us-ascii?Q?qXi9tXDNOkG3iTin1xVNx/k HRMUW1Y+MgNiOLPpX+cOGNIFqI1ZdsK/L6T/U?= =?us-ascii?Q?h0vsGwaKM2lYgcB9mUh9qsHbxn/XJpX0oW4xBivu0uoW5y/X/J5+HMfBQDM9?= =?us-ascii?Q?oCKVWpJiQCLFMyvmSYIuTxox+I4iC3VsR3qlaw+mQggWmfGFo6JqjGFoHgg2?= =?us-ascii?Q?TqJmy/TMKs2EWhSTH4DEt0rkIPpI9w2kPUFZUDwAdEtU3ELqcZ0sQCxDlLSi?= =?us-ascii?Q?nSGlhBV9fQyUKJFxP2LZD3+3bIGmonwZ87Od01q13oosKyq1cxoJv1tQKkSi?= =?us-ascii?Q?7OY63IM8+NTvmvDm6U39C053+DpIWaPxEth269ibiYMMhlce0mBEMmbUrwn1?= =?us-ascii?Q?6c77zQK6OnMszUaRKmVEn/3Myi8=3D?= Content-Language: en-us x-ms-exchange-organization-originalclientipaddress: 213.184.53.4 x-ms-exchange-organization-originalserveripaddress: 10.167.8.103 received-spf: None (mail1.rit.ee: no sender authenticity information available from domain of postmaster@mail.b08.14.p2.message-business.net) identity=helo; client-ip=217.174.213.142; receiver=mail1.rit.ee; envelope-from="r.r16zjobyvpeibgmfzbhgbjafybebhgiveei.3032.54654.6.m@info.edqm-info.eu"; x-sender="postmaster@mail.b08.14.p2.message-business.net"; x-conformance=spf_only dkim-signature: v=1; a=rsa-sha256; d=edqm-info.eu; s=mbdkim1; c=relaxed/simple; t=1782907201; h=from:reply-to:to:subject:date:mime-version:list-unsubscribe; bh=H8l9K9tZ1I5TRw5/Lpc/ssODH/kumGaAdEYTpKSZYjQ=; b=nsjpE6uN694dLfhTWpi4DzZHLg7TiIxnVyf9aiEnfV0Dkx0Uv/wgsAqwfGnggufPkLEFZPV/lca R7wnN9yCi8VnzEHz1f4A9AlYeN7WdHd567vKDcrkkkPqzyLPDZR/1IFiAnDAHHFnpfbj8CPUGhkBv 7twvCguW7ASfBUdxzsQ= X-OlkEid: 00000000D07AAE8E23CDBE4CA04D01CCD82FCB7E070034AD76187591974DBF6C4F76951C873A01000200000000005797C783AAECB34FA6C879FF487E64D9000000000DC800001413547F6191E940BC8DAC96F07D9876 X-Sender: contact@edqm-info.eu X-Campaign-ID: 54654-3032-v2017-05-11.13-50 X-Report-Abuse: Please report abuse on =?us-ascii?q?https=3A=2F=2Finfo=2Eedqm-info=2Eeu=2Fp=2Easpx=3Fu=3D=2Faccount=2F54654=2Freportabuse?= =?us-ascii?q?=2Fr16zjobyvpeibgmfzbhgbjafybebhgiveei=2Faccount=2Easpx=3Fmb=5Fculture=3D?= =?us-ascii?q?en-us&mb=5Fsource=3D3032?= X-MB-Type: Rep-2-C-4 X-Virtual-MTA: b08.14.p2 List-Unsubscribe: =?us-ascii?q?=3Cmailto=3Ar=2Er16zjobyvpeibgmfzbhgbjafybebhgiveei=2E3032=2E54654=2E6=2Em=40?= =?us-ascii?q?info=2Eedqm-info=2Eeu=3Fsubject=3Dunsubscribe=3E=2C?= =?us-ascii?q?_=3Chttps=3A=2F=2Fpublic=2Emessage-business=2Ecom=2Faccount=2F54654=2Funsubscrib?= =?us-ascii?q?e=2Fr16zjobyvpeibgmfzbhgbjafybebhgiveei=2Faccount=2Easpx=3Fmb=5Fculture?= =?us-ascii?q?=3Den-us&mb=5Fsource=3D3032&status=3Dsubmit&formItem-mbsingle-emailop?= =?us-ascii?q?tin=3Dno=3E?= This is a multipart message in MIME format. ------=_NextPart_000_0018_01DD09FC.15B2A260 Content-Type: text/plain; charset="utf-8" Content-Transfer-Encoding: 8bit Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. [Version française plus loin <> ] Take part in our stakeholder survey – Help shape the EDQM Mid-Term Strategy 2028-2031 1 July 2026 Dear Stakeholder, The European Directorate for the Quality of Medicines & HealthCare (EDQM) is undertaking a stakeholder survey between now and 20 August 2026 to gather valuable external perspectives on future priorities, emerging challenges, strategic directions and ways of working. The results of this survey will help inform the EDQM Mid-Term Strategy (MTS) for 2028-2031, now in preparation. Your views are essential to help the EDQM identify where it should focus its efforts, strengthen its role and further improve its services. This survey is a golden opportunity for you to contribute directly to shaping how the EDQM’s work benefits all stakeholders across its different activity areas. The survey questions focus on priorities and key strategic choices and should take approximately 10 minutes to complete. Your input will be carefully analysed and will meaningfully inform the development of our new strategy. All responses will be treated in strict confidence and analysed in aggregate form, unless explicit consent is provided to attribute responses to respondents. We would be grateful if you could complete the survey before 20 August 2026 by clicking on the following link: TAKE PART IN THE EDQM MTS SURVEY Your participation will help ensure that our activities continue to meet the needs and expectations of the diverse, international community the EDQM serves. We thank you in advance for your valuable contribution and continued engagement. Yours faithfully, Petra Doerr Director, EDQM, Council of Europe [Version française] Participez à notre enquête auprès des parties intéressées et contribuez à définir la stratégie à moyen terme de l’EDQM (2028-2031) 1er juillet 2026 Cher/chère partenaire, La Direction européenne de la qualité du médicament & soins de santé (EDQM) mène une enquête auprès de ses parties intéressées d’ici au 20 août 2026 afin de recueillir des avis extérieurs sur ses priorités à venir, ses orientations stratégiques, ses méthodes de travail et les nouveaux défis à relever. Les contributions reçues viendront éclairer l’élaboration de sa stratégie à moyen terme (SMT) pour 2028-2031, actuellement en préparation. Votre avis est essentiel : il aidera l’EDQM à identifier ses champs d’action prioritaires, à renforcer son rôle et à améliorer encore ses services. Pour vous, cette enquête représente une occasion unique d’agir directement sur la manière dont les travaux de l’EDQM bénéficient à l’ensemble de ses parties intéressées dans ses différents domaines d’activité. Les questions portent sur les priorités et les principaux choix stratégiques de l’EDQM. Prévoyez environ 10 minutes pour y répondre. Vos retours seront soigneusement analysés et apporteront des éclairages utiles pour l’élaboration de notre nouvelle stratégie. Toutes les contributions seront traitées de manière strictement confidentielle et sous forme agrégée, sauf autorisation expresse d’associer le nom des personnes interrogées à leurs réponses. Nous vous saurions gré de bien vouloir répondre à l’enquête avant le 20 août 2026 en cliquant sur le lien suivant : PARTICIPER À L’ENQUÊTE SUR LA SMT DE L’EDQM Grâce à votre participation, l’EDQM pourra, au travers de ses activités, continuer de satisfaire les besoins et attentes de la communauté internationale plurielle dont elle sert les intérêts. Merci par avance pour votre précieuse contribution et votre engagement sans cesse renouvelé. Cordialement, Petra Doerr Directrice, EDQM, Conseil de l’Europe EDQM Council of Europe 7 allée Kastner, CS 30026 F-67081 Strasbourg, France www . edqm . eu Tel.: +33 (0)3 88 41 30 30 / Fax: +33 (0)3 88 41 27 71 Unsubscribe / Se désabonner Disclaimer - © EDQM Council of Europe, 2026. All rights reserved.| Contact us | HelpDesk Clause de non responsabilité - © EDQM Conseil de l'Europe, 2026. Tous droits réservés.| Contactez-nous | HelpDesk ------=_NextPart_000_0018_01DD09FC.15B2A260 Content-Type: text/html; charset="utf-8" Content-Transfer-Encoding: quoted-printable Help shape the EDQM Mid-Term Strategy 2028-2031 / Contribuez = =C3=A0 b=C3=A2tir la strat=C3=A9gie =C3=A0 moyen terme de l=E2=80=99EDQM = (2028-2031)

T=C3=A4helepanu! Tegemist on v=C3=A4lisv=C3=B5rgust saabunud kirjaga.
Tundmatu saatja korral palume linke ja faile mitte = avada.
3D"Take
Take part in our stakeholder survey = =E2=80=93 Help shape the EDQM Mid-Term Strategy 2028-2031
1 July 2026

Dear Stakeholder,

The European Directorate for = the Quality of Medicines & HealthCare (EDQM) is undertaking a = stakeholder survey between now and 20 August 2026 to gather valuable external perspectives = on future priorities, emerging challenges, strategic directions and ways = of working. The results of this survey will help inform the EDQM = Mid-Term Strategy (MTS) for 2028-2031, now in preparation.

Your views are essential to = help the EDQM identify where it should focus its efforts, strengthen its = role and further improve its services. This survey is a golden = opportunity for you to contribute directly to shaping how the EDQM=E2=80=99s work benefits all stakeholders across its = different activity areas.

The survey questions focus on = priorities and key strategic choices and should take approximately 10 = minutes to complete.

Your input will be carefully = analysed and will meaningfully inform the development of our new = strategy. All responses will be treated in strict confidence and = analysed in aggregate form, unless explicit consent is provided to attribute responses to respondents.

We would be grateful = if you could complete the survey before 20 August 2026 by clicking on the following = link:

Your participation will help = ensure that our activities continue to meet the needs and expectations = of the diverse, international community the EDQM serves.

We thank you in advance for = your valuable contribution and continued engagement.

Yours faithfully,

Petra Doerr

Director, EDQM, Council of = Europe
 

[Version fran=C3=A7aise]
Participez =C3=A0 = notre enqu=C3=AAte aupr=C3=A8s des parties int=C3=A9ress=C3=A9es et = contribuez =C3=A0 d=C3=A9finir la strat=C3=A9gie =C3=A0 moyen terme de = l=E2=80=99EDQM (2028-2031)
1er juillet 2026

Cher/ch=C3=A8re = partenaire,

La Direction europ=C3=A9enne = de la qualit=C3=A9 du m=C3=A9dicament & soins de sant=C3=A9 = (EDQM) m=C3=A8ne une enqu=C3=AAte aupr=C3=A8s de ses parties = int=C3=A9ress=C3=A9es d=E2=80=99ici au 20 ao=C3=BBt 2026 afin de recueillir des avis = ext=C3=A9rieurs sur ses priorit=C3=A9s =C3=A0 venir, ses orientations = strat=C3=A9giques, ses m=C3=A9thodes de travail et les nouveaux = d=C3=A9fis =C3=A0 relever. Les contributions re=C3=A7ues viendront = =C3=A9clairer l=E2=80=99=C3=A9laboration de sa strat=C3=A9gie =C3=A0 moyen terme (SMT) pour 2028-2031, actuellement en = pr=C3=A9paration.

Votre avis est = essentiel : il aidera l=E2=80=99EDQM =C3=A0 identifier ses champs = d=E2=80=99action prioritaires, =C3=A0 renforcer son r=C3=B4le et =C3=A0 = am=C3=A9liorer encore ses services. Pour vous, cette enqu=C3=AAte = repr=C3=A9sente une occasion unique d=E2=80=99agir directement sur la mani=C3=A8re dont les travaux de l=E2=80=99EDQM = b=C3=A9n=C3=A9ficient =C3=A0 l=E2=80=99ensemble de ses parties = int=C3=A9ress=C3=A9es dans ses diff=C3=A9rents domaines = d=E2=80=99activit=C3=A9.

Les questions portent sur les = priorit=C3=A9s et les principaux choix strat=C3=A9giques de = l=E2=80=99EDQM. Pr=C3=A9voyez environ 10 minutes pour y = r=C3=A9pondre.

Vos retours seront = soigneusement analys=C3=A9s et apporteront des =C3=A9clairages utiles = pour l=E2=80=99=C3=A9laboration de notre nouvelle strat=C3=A9gie. Toutes = les contributions seront trait=C3=A9es de mani=C3=A8re strictement = confidentielle et sous forme agr=C3=A9g=C3=A9e, sauf autorisation expresse d=E2=80=99associer le nom = des personnes interrog=C3=A9es =C3=A0 leurs r=C3=A9ponses.

Nous vous saurions = gr=C3=A9 de bien vouloir r=C3=A9pondre =C3=A0 l=E2=80=99enqu=C3=AAte avant le 20 ao=C3=BBt 2026 en cliquant sur le lien = suivant :

Gr=C3=A2ce =C3=A0 votre = participation, l=E2=80=99EDQM pourra, au travers de ses activit=C3=A9s, = continuer de satisfaire les besoins et attentes de la communaut=C3=A9 = internationale plurielle dont elle sert les int=C3=A9r=C3=AAts.

Merci par avance pour votre = pr=C3=A9cieuse contribution et votre engagement sans cesse = renouvel=C3=A9.

Cordialement,

Petra Doerr

Directrice, EDQM, Conseil de = l=E2=80=99Europe
3D"Linkedin"
 
3D"X"
 
3D"Facebook"

EDQM Council of Europe =

7 all=C3=A9e Kastner, CS = 30026

F-67081 Strasbourg, France

www.edqm.eu

Tel.: +33 (0)3 88 41 30 30 = / Fax: +33 (0)3 88 41 27 71

Disclaimer - =C2=A9 EDQM Council of Europe, 2026. All rights reserved.| Contact us | HelpDesk

Clause de non responsabilit=C3=A9 - =C2=A9 EDQM Conseil de l'Europe, 2026. = Tous droits r=C3=A9serv=C3=A9s.| Contactez-nous | HelpDesk
3D"Download
------=_NextPart_000_0018_01DD09FC.15B2A260--